Close Menu


The Children's Hospital of Philadelphia said last week that it plans to begin offering clinical sequencing services through two different labs.

NEW YORK (GenomeWeb News) – Two additional lawsuits have been filed seeking to block BGI's $117.6 million purchase of Complete Genomics.

BGI is separating its commercial activities from its research activities, launching BGI Tech and BGI Health as commercial arms that will operate as subsidiaries of BGI and will focus on sequencing services and related products for the research and clinical markets, respectively.

NEW YORK (GenomeWeb News) – Two lawsuits have been filed against Complete Genomics and BGI alleging a breach of fiduciary duties stemming from BGI's planned $117.6 million purchase of Complete Genomics.

NEW YORK (GenomeWeb News) – BGI and the Bill & Melinda Gates Foundation have inked a memorandum of understanding to collaborate on applying genomic tools to improving global health and agricultural development.

NEW YORK (GenomeWeb News) – Women's health diagnostics company Inex Innovations Exchange announced today a partnership with BGI to create a next-generation sequencing facility in Singapore to offer molecular genetic tests.

NEW YORK (GenomeWeb News) – In a study appearing online today in Nature, an international team led by investigators in China, Denmark, the US, and Hong Kong described findings from its genomic, transcriptomic, and proteomic study of the Pacific oyster, Crassostrea gigas.

BGI's proposed takeover of Complete Genomics might be a win-win for both partners as well as for customers, according to industry observers and current users of Complete's whole-genome sequencing service.

NEW YORK (GenomeWeb News) – More than three months after it began a review of its strategic alternatives, Complete Genomics along with BGI-Shenzhen today announced a

Researchers from BGI have analyzed the advantages and disadvantages of each major sequencing platform, assessing features such as cost, accuracy, throughput, read length, and the applications each are suited to.


According to ScienceInsider, the US National Academies of Science, Engineering, and Medicine is planning a study of racism in academic research.

The Washington Post writes that the approval in the US of a SARS-CoV-2 vaccine will be up to Peter Marks, a career official at the Food and Drug Administration.

NPR reports the US loan to Eastman Kodak to boost domestic pharmaceutical production is on pause following insider trading allegations.

In Cell this week: blood immune cell changes in COVID-19 patients and spatial transcriptomics in Alzheimer's disease.